CoChat

Adreno-leukodystrophy: Oxidative Stress of Mice and Men

Open access
Powers, James M, Pei, Zhengtong, Heinzer, Ann K, Deering, Rebecca, Moser, Ann B, Moser, Hugo W, Watkins, Paul A, Smith, Kirby D · 2005 · Journal of Neuropathology and Experimental Neurology
Cited by 129

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

X-linked adreno-leukodystrophy is a progressive, systemic peroxisomal disorder that affects primarily nervous system myelin and axons as well as the adrenal cortex. Several divergent clinical phenotypes can occur in the same family; thus, there is no correlation between the clinical phenotype and the mutation in the ABCD1 gene in this disease. The most urgent and unresolved clinical issue is the fulminant inflammatory (immune) demyelination of the central nervous system in which a variety of cellular participants, cytokines, and chemokines are noted. A knockout mouse model exhibits mitochondrial deficits and axonal degeneration, but not inflammatory demyelination. To determine whether oxidative stress and damage might play a pathogenic role, we assessed standard biochemical and immunohistochemical markers of such activity both in our knockout mouse model and patients. We find that oxidative stress, as judged by increased immunoreactivity for the mitochondrial manganese-superoxide dismutase, is present in the knockout mouse liver, adrenal cortex, and renal cortex, tissues that normally express high levels of ABCD1 but no evidence of oxidative damage. The brain does not exhibit either oxidative stress or damage. On the other hand, both the human adrenal cortex and brain show evidence of oxidative stress (e.g. hemoxygenase-1 and manganese-superoxide dismutase) and oxidative damage, particularly from lipid peroxidation (4-hydroxynonenal and malondialdehyde). The presence of nitrotyrosylated proteins is strong circumstantial evidence for the participation of the highly toxic peroxynitrite molecule, whereas the demonstration of interferon gamma and interleukin-12 is indicative of a TH1 response in the inflammatory demyelinative lesions of the cerebral phenotype. These differences between the adreno-leukodystrophy mouse and human patients are intriguing and may provide a clue to the phenotypic divergence in this disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/01.jnen.0000190064.28559.a4

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Research works printed but not linked: 27

  1. Schaumburg, 1975, Arch Neurol, 33, 577, 10.1001/archneur.1975.00490510033001 · DOI · Paper page
  2. Powers, 1980, Invest Cell Pathol, 3, 353
  3. Powers, 1985, Clin Neuropathol, 4, 181
  4. Migeon, 1981, Proc Natl Acad Sci U S A, 78, 5066, 10.1073/pnas.78.8.5066 · DOI · Paper page
  5. Heinzer, 2003, Adv Exp Med Biol, 544, 75, 10.1007/978-1-4419-9072-3_12 · DOI
  6. Tsuji, 1984, J Biochem, 96, 1241, 10.1093/oxfordjournals.jbchem.a134942 · DOI · Paper page
  7. Forss-Petter, 1997, J Neurosci Res, 50, 829, 10.1002/(SICI)1097-4547(19971201)50:5<829::AID-JNR19>3.0.CO;2-W · doi:10.1002/(sici)1097-4547(19971201)50:5<829::aid-jnr19>3.0.co;2-w
  8. Powers, 2000, J Neuropathol Exp Neurol, 59, 89, 10.1093/jnen/59.2.89 · DOI · Paper page
  9. Meij, 2004, Mol Pharmacol, 66, 1043, 10.1124/mol.104.001354 · DOI
  10. Vargas, 2004, Biochim Biophys Acta, 1688, 26, 10.1016/j.bbadis.2003.10.004 · DOI
  11. Halliwell, 1985, TINS, 8, 22
  12. Watkins, 1995, Am J Hum Genet, 57, 292
  13. Mihara, 1978, Anal Biochem, 86, 271, 10.1016/0003-2697(78)90342-1 · DOI · Paper page
  14. Reznick, 1994, Methods Enzymol, 233, 357, 10.1016/S0076-6879(94)33041-7 · DOI · Paper page
  15. Allen, 1982, South Med J, 75, 877, 10.1097/00007611-198207000-00031 · DOI · Paper page
  16. Connor, 1996, Glia, 17, 83, 10.1002/(SICI)1098-1136(199606)17:2<83::AID-GLIA1>3.0.CO;2-7 · doi:10.1002/(sici)1098-1136(199606)17:2<83::aid-glia1>3.0.co;2-7
  17. Sanyal, 1995, Soc Neurosci Abstr, 21, 3
  18. Mancuso, 2005, J Neuropathol Exp Neurol, 64, 280, 10.1093/jnen/64.4.280 · DOI · Paper page
  19. Vig, 2004, J Clin Invest, 113, 1734, 10.1172/JCI20225 · doi:10.1172/jci20225 · Paper page
  20. Meij, 2004, Mol Pharmacol, 66, 1043, 10.1124/mol.104.001354 · DOI
  21. Bonfoco, 1995, Proc Natl Acad Sci U S A, 92, 7162, 10.1073/pnas.92.16.7162 · DOI · Paper page
  22. Mitrovic, 1995, Neuroscience, 65, 531, 10.1016/0306-4522(94)00491-M · DOI · Paper page
  23. Montine, 2002, Free Radic Biol Med, 33, 620, 10.1016/S0891-5849(02)00807-9 · DOI · Paper page
  24. Di Biase, 2001, J Neurol Sci, 182, 161, 10.1016/S0022-510X(00)00469-X · DOI
  25. Paintlia, 2003, Neurobiol Dis, 14, 425, 10.1016/j.nbd.2003.08.013 · DOI · Paper page
  26. Dong, 2001, Glia, 36, 180, 10.1002/glia.1107 · DOI · Paper page
  27. Aloisi, 2001, Glia, 36, 165, 10.1002/glia.1106 · DOI · Paper page

Cited by

See all 129

Metadata

Authors
Powers, J. M., Pei, Z., Heinzer, A. K., Deering, R., Moser, A. B., Moser, H. W., Watkins, P. A., & Smith, K. D.
Venue
Journal of Neuropathology and Experimental Neurology
Published
2005-12
Volume
64
Issue
12
Pages
1067-1079
ISSN
0022-3069 (ISSN-L)
OpenAlex
W1968679005
Cited by
129
References
16
FWCI
4.67
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Adreno-leukodystrophy: Oxidative Stress of Mice and Men. https://app.cochat.ai/papers/10.1097/01.jnen.0000190064.28559.a4
The paper
Powers, J. M., Pei, Z., Heinzer, A. K., Deering, R., Moser, A. B., Moser, H. W., Watkins, P. A., & Smith, K. D. (2005). Adreno-leukodystrophy: Oxidative Stress of Mice and Men. Journal of Neuropathology and Experimental Neurology. https://doi.org/10.1097/01.jnen.0000190064.28559.a4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.